Press releases
Browse LEO Pharma’s global press releases intended for media.
Press releases issued by our local operating companies can be viewed on our market websites.
-
Globally known professor and dermatologist joins LEO Pharma
Globally known professor and dermatologist joins LEO Pharma Ahead of EADV, LEO Pharma announces that Professor Alexander Egeberg, a board-certified dermatologist, and top key opinion leader, will join…
-
LEO Pharma delivers solid first half-year results and strengthens its capital structure
LEO Pharma delivers solid first half-year results and strengthens its capital structure Ballerup, September 12, 2023 – Today, LEO Pharma announced results for first half 2023 and an…
-
LEO Pharma announces changes to its Global Leadership Team
LEO Pharma announces changes to its Global Leadership Team Ballerup, August 28, 2023 – Today, LEO Pharma announced the appointment of Nathalie Daste as new Executive Vice President,…
-
LEO Pharma Signs Agreement to Acquire Timber Pharmaceutical
LEO Pharma Signs Agreement to Acquire Timber Pharmaceutical Ballerup, August 21, 2023 – LEO Pharma today announced that it signed an agreement to acquire U.S.-listed Timber Pharmaceuticals, Inc. (NYSE…
-
LEO Pharma announces changes to its Global Leadership Team
LEO Pharma announces changes to its Global Leadership Team Ballerup, August 28, 2023 – Today, LEO Pharma announced the appointment of Nathalie Daste as new Executive Vice President,…
-
LEO Pharma adds internationally recognized dermatologist to Global Leadership Team
LEO Pharma adds internationally recognized dermatologist to Global Leadership Team Ballerup, March 14, 2023 – LEO Pharma today announced a split of its R&D organization into two distinct functions.…
-
LEO Pharma and ICON enter a Strategic Partnership to propel clinical trial execution within medical dermatology
LEO Pharma and ICON enter a Strategic Partnership to propel clinical trial execution within medical dermatology BALLERUP, DENMARK and DUBLIN, IRELAND — March 10, 2023 — LEO Pharma, a global…
-
LEO Pharma announces annual results 2023
LEO Pharma announces annual results 2023 LEO Pharma delivers 10% revenue growth and returns to positive EBITDA Ballerup, February 29, 2024. – LEO Pharma delivers a solid operational…
-
LEO Pharma announces annual results 2022
LEO Pharma announces annual results 2022 Progressing on the financial turnaround, delivering a result in line with guidance, driven by solid growth in dermatology Today, LEO Pharma released…
-
Delivering a financial turnaround of LEO Pharma
Delivering a financial turnaround of LEO Pharma Ballerup – January 13: LEO Pharma is committed to being a global leader in medical dermatology by bringing innovative treatments to…
Media Inquiries
Head of Media
+4530502014
JEILK@leo-pharma.com
SVP, Head of Corporate Communications
+4529407016
ANMRN@leo-pharma.com
Media Manager
+4553748849
CHBUN@leo-pharma.com
About LEO Pharma
LEO Pharma is a global leader in medical dermatology. We deliver innovative solutions for skin health, building on a century of experience with breakthrough medicines in healthcare. We are committed to making a fundamental difference in people’s lives, and our broad portfolio of treatments serves close to 100 million patients in over 70 countries annually. Headquartered in Denmark, LEO Pharma has a team of 4,000 people worldwide. LEO Pharma is co-owned by majority shareholder the LEO Foundation and, since 2021, Nordic Capital. For more information, visit www.leo-pharma.com
Our press releases are intended for the media
To comply with applicable regulation, product-related press releases are removed from our website within three weeks of publication. They are available upon request. For updated information about clinical trials, please visit https://clinicaltrials.gov/.